Development of successful controlled release dosage forms
- At: 2005 FIP Congress in Cairo (Egypt)
- Type: Presentation
- By: SAKR, Adel (University of Cincinnati, College of Pharmacy, Cincinnati, United States of America)
This presentation summarizes some of the work which we carried out recently. Once/Day Propranolol Tablet: using Kollidon SR, controlled release Propranolol tablets were developed and tested in humans in comparison with the market product Inderal LA Capsules. The developed tablets succeeded in extending the release of Propranolol over 24 hours.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.